<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-12-01" modified="2020-10-07" version="238">
<accession>P29353</accession>
<accession>B5BU19</accession>
<accession>D3DV78</accession>
<accession>O15290</accession>
<accession>Q5T180</accession>
<accession>Q5T183</accession>
<accession>Q5T184</accession>
<accession>Q5T185</accession>
<accession>Q5T186</accession>
<accession>Q8N4K5</accession>
<accession>Q96CL1</accession>
<name>SHC1_HUMAN</name>
<protein>
<recommendedName>
<fullName>SHC-transforming protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>SHC-transforming protein 3</fullName>
</alternativeName>
<alternativeName>
<fullName>SHC-transforming protein A</fullName>
</alternativeName>
<alternativeName>
<fullName>Src homology 2 domain-containing-transforming protein C1</fullName>
<shortName>SH2 domain protein C1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SHC1</name>
<name type="synonym">SHC</name>
<name type="synonym">SHCA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Cell" volume="70" first="93" last="104">
<title>A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.</title>
<authorList>
<person name="Pelicci G."/>
<person name="Lanfrancone L."/>
<person name="Grignani F."/>
<person name="McGlade J."/>
<person name="Cavallo F."/>
<person name="Forni G."/>
<person name="Nicoletti I."/>
<person name="Grignani F."/>
<person name="Pawson T."/>
<person name="Pelicci P.-G."/>
</authorList>
<dbReference type="PubMed" id="1623525"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90536-l"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS P46SHC AND P52SHC)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="706" last="716">
<title>Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.</title>
<authorList>
<person name="Migliaccio E."/>
<person name="Mele S."/>
<person name="Salcini A.E."/>
<person name="Pelicci G."/>
<person name="Lai K.M."/>
<person name="Superti-Furga G."/>
<person name="Pawson T."/>
<person name="Di Fiore P.P."/>
<person name="Lanfrancone L."/>
<person name="Pelicci P.-G."/>
</authorList>
<dbReference type="PubMed" id="9049300"/>
<dbReference type="DOI" id="10.1093/emboj/16.4.706"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM P66SHC)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Genomics" volume="42" first="349" last="352">
<title>Characterization of human SHC p66 cDNA and its processed pseudogene mapping to Xq12-q13.1.</title>
<authorList>
<person name="Harun R.B."/>
<person name="Smith K.K."/>
<person name="Leek J.P."/>
<person name="Markham A.F."/>
<person name="Norris A."/>
<person name="Morrison J.F."/>
</authorList>
<dbReference type="PubMed" id="9192859"/>
<dbReference type="DOI" id="10.1006/geno.1997.4728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM P52SHC)</scope>
<source>
<tissue>Mammary gland</tissue>
<tissue>Synovium</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS P52SHC AND 7)</scope>
<source>
<tissue>Choriocarcinoma</tissue>
<tissue>Neuroblastoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="15337" last="15343">
<title>Direct interaction between Shc and the platelet-derived growth factor beta-receptor.</title>
<authorList>
<person name="Yokote K."/>
<person name="Mori S."/>
<person name="Hansen K."/>
<person name="McGlade J."/>
<person name="Pawson T."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8195171"/>
</citation>
<scope>INTERACTION WITH PDGFRB AND GRB2</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="Neuron" volume="12" first="691" last="705">
<title>Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses.</title>
<authorList>
<person name="Stephens R.M."/>
<person name="Loeb D.M."/>
<person name="Copeland T.D."/>
<person name="Pawson T."/>
<person name="Greene L.A."/>
<person name="Kaplan D.R."/>
</authorList>
<dbReference type="PubMed" id="8155326"/>
<dbReference type="DOI" id="10.1016/0896-6273(94)90223-2"/>
</citation>
<scope>INTERACTION WITH NTRK1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="15639" last="15643">
<title>Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.</title>
<authorList>
<person name="Craparo A."/>
<person name="O'Neill T.J."/>
<person name="Gustafson T.A."/>
</authorList>
<dbReference type="PubMed" id="7541045"/>
<dbReference type="DOI" id="10.1074/jbc.270.26.15639"/>
</citation>
<scope>INTERACTION WITH IGF1R</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="23258" last="23262">
<title>Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains.</title>
<authorList>
<person name="He W."/>
<person name="O'Neill T.J."/>
<person name="Gustafson T.A."/>
</authorList>
<dbReference type="PubMed" id="7559478"/>
<dbReference type="DOI" id="10.1074/jbc.270.40.23258"/>
</citation>
<scope>INTERACTION WITH INSR</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="2500" last="2508">
<title>Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.</title>
<authorList>
<person name="Gustafson T.A."/>
<person name="He W."/>
<person name="Craparo A."/>
<person name="Schaub C.D."/>
<person name="O'Neill T.J."/>
</authorList>
<dbReference type="PubMed" id="7537849"/>
<dbReference type="DOI" id="10.1128/mcb.15.5.2500"/>
</citation>
<scope>INTERACTION WITH INSR</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="Blood" volume="88" first="2833" last="2840">
<title>Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation.</title>
<authorList>
<person name="Ware M.D."/>
<person name="Rosten P."/>
<person name="Damen J.E."/>
<person name="Liu L."/>
<person name="Humphries R.K."/>
<person name="Krystal G."/>
</authorList>
<dbReference type="PubMed" id="8874179"/>
</citation>
<scope>INTERACTION WITH INPP5D</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1996" name="Curr. Biol." volume="6" first="1435" last="1444">
<title>The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.</title>
<authorList>
<person name="van der Geer P."/>
<person name="Wiley S."/>
<person name="Gish G.D."/>
<person name="Pawson T."/>
</authorList>
<dbReference type="PubMed" id="8939605"/>
<dbReference type="DOI" id="10.1016/s0960-9822(96)00748-8"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-349 AND TYR-350</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="30942" last="30949">
<title>Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.</title>
<authorList>
<person name="Yokote K."/>
<person name="Margolis B."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8940081"/>
<dbReference type="DOI" id="10.1074/jbc.271.48.30942"/>
</citation>
<scope>INTERACTION WITH GRB7</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="5915" last="5920">
<title>Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes.</title>
<authorList>
<person name="Price D.J."/>
<person name="Rivnay B."/>
<person name="Fu Y."/>
<person name="Jiang S."/>
<person name="Avraham S."/>
<person name="Avraham H."/>
</authorList>
<dbReference type="PubMed" id="9038210"/>
<dbReference type="DOI" id="10.1074/jbc.272.9.5915"/>
</citation>
<scope>INTERACTION WITH KIT</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="13189" last="13195">
<title>Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src.</title>
<authorList>
<person name="Schlaepfer D.D."/>
<person name="Hunter T."/>
</authorList>
<dbReference type="PubMed" id="9148935"/>
<dbReference type="DOI" id="10.1074/jbc.272.20.13189"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="1824" last="1831">
<title>Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation.</title>
<authorList>
<person name="Gotoh N."/>
<person name="Toyoda M."/>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="9121430"/>
<dbReference type="DOI" id="10.1128/mcb.17.4.1824"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-349; TYR-350 AND TYR-427</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="7" last="15">
<title>Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation.</title>
<authorList>
<person name="Yokouchi M."/>
<person name="Suzuki R."/>
<person name="Masuhara M."/>
<person name="Komiya S."/>
<person name="Inoue A."/>
<person name="Yoshimura A."/>
</authorList>
<dbReference type="PubMed" id="9233773"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201163"/>
</citation>
<scope>INTERACTION WITH APS</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="18605" last="18609">
<title>Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein.</title>
<authorList>
<person name="Habib T."/>
<person name="Hejna J.A."/>
<person name="Moses R.E."/>
<person name="Decker S.J."/>
</authorList>
<dbReference type="PubMed" id="9660833"/>
<dbReference type="DOI" id="10.1074/jbc.273.29.18605"/>
</citation>
<scope>INTERACTION WITH INPP5D AND INPPL1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="1622" last="1634">
<title>Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase.</title>
<authorList>
<person name="Tiganis T."/>
<person name="Bennett A.M."/>
<person name="Ravichandran K.S."/>
<person name="Tonks N.K."/>
</authorList>
<dbReference type="PubMed" id="9488479"/>
<dbReference type="DOI" id="10.1128/mcb.18.3.1622"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN2</scope>
<scope>MUTAGENESIS OF TYR-349 AND TYR-427</scope>
<scope>INTERACTION WITH GRB2</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="2571" last="2585">
<title>Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.</title>
<authorList>
<person name="Schlaepfer D.D."/>
<person name="Jones K.C."/>
<person name="Hunter T."/>
</authorList>
<dbReference type="PubMed" id="9566877"/>
<dbReference type="DOI" id="10.1128/mcb.18.5.2571"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-349; TYR-350 AND TYR-427</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="Blood" volume="93" first="2707" last="2720">
<title>A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.</title>
<authorList>
<person name="Wisniewski D."/>
<person name="Strife A."/>
<person name="Swendeman S."/>
<person name="Erdjument-Bromage H."/>
<person name="Geromanos S."/>
<person name="Kavanaugh W.M."/>
<person name="Tempst P."/>
<person name="Clarkson B."/>
</authorList>
<dbReference type="PubMed" id="10194451"/>
</citation>
<scope>INTERACTION WITH INPPL1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="19803" last="19807">
<title>Ligand discrimination in signaling through an ErbB4 receptor homodimer.</title>
<authorList>
<person name="Sweeney C."/>
<person name="Lai C."/>
<person name="Riese D.J. II"/>
<person name="Diamonti A.J."/>
<person name="Cantley L.C."/>
<person name="Carraway K.L. III"/>
</authorList>
<dbReference type="PubMed" id="10867024"/>
<dbReference type="DOI" id="10.1074/jbc.c901015199"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="28348" last="28355">
<title>The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells.</title>
<authorList>
<person name="Pesesse X."/>
<person name="Dewaste V."/>
<person name="De Smedt F."/>
<person name="Laffargue M."/>
<person name="Giuriato S."/>
<person name="Moreau C."/>
<person name="Payrastre B."/>
<person name="Erneux C."/>
</authorList>
<dbReference type="PubMed" id="11349134"/>
<dbReference type="DOI" id="10.1074/jbc.m103537200"/>
</citation>
<scope>INTERACTION WITH INPPL1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="2699" last="2707">
<title>Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples.</title>
<authorList>
<person name="Hecker T.P."/>
<person name="Grammer J.R."/>
<person name="Gillespie G.Y."/>
<person name="Stewart J. Jr."/>
<person name="Gladson C.L."/>
</authorList>
<dbReference type="PubMed" id="11980671"/>
</citation>
<scope>INTERACTION WITH PTK2/FAK1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="22370" last="22376">
<title>The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter.</title>
<authorList>
<person name="Ventura A."/>
<person name="Luzi L."/>
<person name="Pacini S."/>
<person name="Baldari C.T."/>
<person name="Pelicci P.-G."/>
</authorList>
<dbReference type="PubMed" id="11948181"/>
<dbReference type="DOI" id="10.1074/jbc.m200280200"/>
</citation>
<scope>ALTERNATIVE PROMOTER USAGE</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="J. Cell Biol." volume="162" first="661" last="671">
<title>EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis.</title>
<authorList>
<person name="Vindis C."/>
<person name="Cerretti D.P."/>
<person name="Daniel T.O."/>
<person name="Huynh-Do U."/>
</authorList>
<dbReference type="PubMed" id="12925710"/>
<dbReference type="DOI" id="10.1083/jcb.200302073"/>
</citation>
<scope>INTERACTION WITH EPHB1 AND GRB2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Cancer Cell" volume="6" first="347" last="360">
<title>TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.</title>
<authorList>
<person name="Tacconelli A."/>
<person name="Farina A.R."/>
<person name="Cappabianca L."/>
<person name="Desantis G."/>
<person name="Tessitore A."/>
<person name="Vetuschi A."/>
<person name="Sferra R."/>
<person name="Rucci N."/>
<person name="Argenti B."/>
<person name="Screpanti I."/>
<person name="Gulino A."/>
<person name="Mackay A.R."/>
</authorList>
<dbReference type="PubMed" id="15488758"/>
<dbReference type="DOI" id="10.1016/j.ccr.2004.09.011"/>
</citation>
<scope>INTERACTION WITH NTRK1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW ON ROLE IN KIT SIGNALING</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="13224" last="13233">
<title>Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells.</title>
<authorList>
<person name="Audero E."/>
<person name="Cascone I."/>
<person name="Maniero F."/>
<person name="Napione L."/>
<person name="Arese M."/>
<person name="Lanfrancone L."/>
<person name="Bussolino F."/>
</authorList>
<dbReference type="PubMed" id="14665640"/>
<dbReference type="DOI" id="10.1074/jbc.m307456200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH TEK</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="27088" last="27097">
<title>Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress.</title>
<authorList>
<person name="Wang J.F."/>
<person name="Zhang X."/>
<person name="Groopman J.E."/>
</authorList>
<dbReference type="PubMed" id="15102829"/>
<dbReference type="DOI" id="10.1074/jbc.m314015200"/>
</citation>
<scope>INTERACTION WITH FLT4</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="46438" last="46447">
<title>Tyrosine phosphoproteomics of fibroblast growth factor signaling: a role for insulin receptor substrate-4.</title>
<authorList>
<person name="Hinsby A.M."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="15316024"/>
<dbReference type="DOI" id="10.1074/jbc.m404537200"/>
</citation>
<scope>INTERACTION WITH IRS4</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="2299" last="2306">
<title>A cryptic targeting signal induces isoform-specific localization of p46Shc to mitochondria.</title>
<authorList>
<person name="Ventura A."/>
<person name="Maccarana M."/>
<person name="Raker V.A."/>
<person name="Pelicci P.-G."/>
</authorList>
<dbReference type="PubMed" id="14573619"/>
<dbReference type="DOI" id="10.1074/jbc.m307655200"/>
</citation>
<scope>SUBCELLULAR LOCATION (ISOFORM P46SHC)</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="40536" last="40544">
<title>Serine and threonine phosphorylation of the low density lipoprotein receptor-related protein by protein kinase Calpha regulates endocytosis and association with adaptor molecules.</title>
<authorList>
<person name="Ranganathan S."/>
<person name="Liu C.-X."/>
<person name="Migliorini M.M."/>
<person name="Von Arnim C.A.F."/>
<person name="Peltan I.D."/>
<person name="Mikhailenko I."/>
<person name="Hyman B.T."/>
<person name="Strickland D.K."/>
</authorList>
<dbReference type="PubMed" id="15272003"/>
<dbReference type="DOI" id="10.1074/jbc.m407592200"/>
</citation>
<scope>INTERACTION WITH LRP1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="169" first="331" last="339">
<title>Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity.</title>
<authorList>
<person name="Smith W.W."/>
<person name="Norton D.D."/>
<person name="Gorospe M."/>
<person name="Jiang H."/>
<person name="Nemoto S."/>
<person name="Holbrook N.J."/>
<person name="Finkel T."/>
<person name="Kusiak J.W."/>
</authorList>
<dbReference type="PubMed" id="15837797"/>
<dbReference type="DOI" id="10.1083/jcb.200410041"/>
</citation>
<scope>PHOSPHORYLATION AT SER-36</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="727" last="734">
<title>ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation.</title>
<authorList>
<person name="Degoutin J."/>
<person name="Vigny M."/>
<person name="Gouzi J.Y."/>
</authorList>
<dbReference type="PubMed" id="17274988"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.01.039"/>
</citation>
<scope>INTERACTION WITH ALK</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2305" last="2316">
<title>Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.</title>
<authorList>
<person name="Brummer T."/>
<person name="Larance M."/>
<person name="Herrera Abreu M.T."/>
<person name="Lyons R.J."/>
<person name="Timpson P."/>
<person name="Emmerich C.H."/>
<person name="Fleuren E.D.G."/>
<person name="Lehrbach G.M."/>
<person name="Schramek D."/>
<person name="Guilhaus M."/>
<person name="James D.E."/>
<person name="Daly R.J."/>
</authorList>
<dbReference type="PubMed" id="19172738"/>
<dbReference type="DOI" id="10.1038/emboj.2008.159"/>
</citation>
<scope>INTERACTION WITH GAB2</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND TYR-427</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-427</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Oncogene" volume="29" first="1598" last="1610">
<title>Copine-III interacts with ErbB2 and promotes tumor cell migration.</title>
<authorList>
<person name="Heinrich C."/>
<person name="Keller C."/>
<person name="Boulay A."/>
<person name="Vecchi M."/>
<person name="Bianchi M."/>
<person name="Sack R."/>
<person name="Lienhard S."/>
<person name="Duss S."/>
<person name="Hofsteenge J."/>
<person name="Hynes N.E."/>
</authorList>
<dbReference type="PubMed" id="20010870"/>
<dbReference type="DOI" id="10.1038/onc.2009.456"/>
</citation>
<scope>INTERACTION WITH CPNE3</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORMS 7 AND P52SHC)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139; TYR-427 AND SER-453</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2013" name="J. Virol." volume="87" first="11276" last="11286">
<title>Role of herpes simplex virus VP11/12 tyrosine-based motifs in binding and activation of the Src family kinase Lck and recruitment of p85, Grb2, and Shc.</title>
<authorList>
<person name="Strunk U."/>
<person name="Saffran H.A."/>
<person name="Wu F.W."/>
<person name="Smiley J.R."/>
</authorList>
<dbReference type="PubMed" id="23946459"/>
<dbReference type="DOI" id="10.1128/jvi.01702-13"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 UL46 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2013" name="Nature" volume="499" first="166" last="171">
<title>Temporal regulation of EGF signalling networks by the scaffold protein Shc1.</title>
<authorList>
<person name="Zheng Y."/>
<person name="Zhang C."/>
<person name="Croucher D.R."/>
<person name="Soliman M.A."/>
<person name="St-Denis N."/>
<person name="Pasculescu A."/>
<person name="Taylor L."/>
<person name="Tate S.A."/>
<person name="Hardy W.R."/>
<person name="Colwill K."/>
<person name="Dai A.Y."/>
<person name="Bagshaw R."/>
<person name="Dennis J.W."/>
<person name="Gingras A.C."/>
<person name="Daly R.J."/>
<person name="Pawson T."/>
</authorList>
<dbReference type="PubMed" id="23846654"/>
<dbReference type="DOI" id="10.1038/nature12308"/>
</citation>
<scope>INTERACTION WITH PEAK1</scope>
<scope>INTERACTION WITH PPP1CA</scope>
<scope>PPP1CC AND PEAK1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="1995" name="J. Mol. Biol." volume="254" first="86" last="95">
<title>Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data.</title>
<authorList>
<person name="Mikol V."/>
<person name="Baumann G."/>
<person name="Zurini M.G.M."/>
<person name="Hommel U."/>
</authorList>
<dbReference type="PubMed" id="7473762"/>
<dbReference type="DOI" id="10.1006/jmbi.1995.0601"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 482-583</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1995" name="Nature" volume="378" first="584" last="592">
<title>Structure and ligand recognition of the phosphotyrosine binding domain of Shc.</title>
<authorList>
<person name="Zhou M.-M."/>
<person name="Ravichandran K.S."/>
<person name="Olejniczak E.F."/>
<person name="Petros A.M."/>
<person name="Meadows R.P."/>
<person name="Sattler M."/>
<person name="Harlan J.E."/>
<person name="Wade W.S."/>
<person name="Burakoff S.J."/>
<person name="Fesik S.W."/>
</authorList>
<dbReference type="PubMed" id="8524391"/>
<dbReference type="DOI" id="10.1038/378584a0"/>
</citation>
<scope>STRUCTURE BY NMR OF 127-317</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="7784" last="7788">
<title>Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor.</title>
<authorList>
<person name="Zhou M.-M."/>
<person name="Meadows R.P."/>
<person name="Logan T.M."/>
<person name="Yoon H.S."/>
<person name="Wade W.S."/>
<person name="Ravichandran K.S."/>
<person name="Burakoff S.J."/>
<person name="Fesik S.W."/>
</authorList>
<dbReference type="PubMed" id="7544002"/>
<dbReference type="DOI" id="10.1073/pnas.92.17.7784"/>
</citation>
<scope>STRUCTURE BY NMR OF 480-583 IN COMPLEX WITH TYROSINE-PHOSPHORYLATED CD3Z</scope>
</reference>
<comment type="function">
<text evidence="15 26">Signaling adapter that couples activated growth factor receptors to signaling pathways. Participates in a signaling cascade initiated by activated KIT and KITLG/SCF. Isoform p46Shc and isoform p52Shc, once phosphorylated, couple activated receptor tyrosine kinases to Ras via the recruitment of the GRB2/SOS complex and are implicated in the cytoplasmic propagation of mitogenic signals. Isoform p46Shc and isoform p52Shc may thus function as initiators of the Ras signaling cascade in various non-neuronal systems. Isoform p66Shc does not mediate Ras activation, but is involved in signal transduction pathways that regulate the cellular response to oxidative stress and life span. Isoform p66Shc acts as a downstream target of the tumor suppressor p53 and is indispensable for the ability of stress-activated p53 to induce elevation of intracellular oxidants, cytochrome c release and apoptosis. The expression of isoform p66Shc has been correlated with life span (By similarity). Participates in signaling downstream of the angiopoietin receptor TEK/TIE2, and plays a role in the regulation of endothelial cell migration and sprouting angiogenesis.</text>
</comment>
<comment type="subunit">
<text evidence="16 17 20 21 22 23 24 26 27 28 29 30 33 34 35 36 38 39 40 41 42 43 44 46 47 50 51 53">Interacts with CPNE3; this interaction may mediate the binding of CPNE3 with ERBB2 (PubMed:20010870). Interacts with the NPXY motif of tyrosine-phosphorylated IGF1R and INSR in vitro via the PID domain. Once activated, binds to GRB2. Interacts with tyrosine-phosphorylated CD3T and DDR2. Interacts with the N-terminal region of APS. Interacts with phosphorylated LRP1 and IRS4. Interacts with INPP5D/SHIP1 and INPPL1/SHIP2. Interacts with TRIM31. Interacts with PTPN6/SHP (tyrosine phosphorylated). Identified in a complex containing FGFR4, NCAM1, CDH2, PLCG1, FRS2, SRC, SHC1, GAP43 and CTT (By similarity). Interacts with ALK, GAB2, GRB7 and KIT. Interacts with FLT4 (tyrosine-phosphorylated). Interacts with EPHB1 and GRB2; activates the MAPK/ERK cascade to regulate cell migration. Interacts with PDGFRB (tyrosine-phosphorylated). Interacts with ERBB4. Interacts with TEK/TIE2 (tyrosine-phosphorylated). Interacts with the Trk receptors NTRK1, NTRK2 and NTRK3; in a phosphotyrosine-dependent manner. Interacts with PTK2/FAK1. Interacts with CEACAM1; this interaction is CEACAM1-phosphorylation-dependent and mediates interaction with EGFR or INSR resulting in decrease coupling of SHC1 to the MAPK3/ERK1-MAPK1/ERK2 pathway (By similarity). Interacts (via PID domain) with PEAK1 (when phosphorylated at 'Tyr-1188') (PubMed:23846654). Found in a complex with PPP1CA, PPP1CC, SHC1 and PEAK1 (PubMed:23846654).</text>
</comment>
<comment type="subunit">
<text evidence="37">(Microbial infection) Interacts with herpes simplex virus 1 UL46.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-77613">
<id>P05067</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-739580">
<id>Q13137</id>
<label>CALCOCO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>34</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-4309277">
<id>P03372-4</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>27</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-475899">
<id>P06213</id>
<label>INSR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-297487">
<id>Q07889</id>
<label>SOS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-646604">
<id>Q62120</id>
<label>Jak2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78835">
<id>P29353</id>
</interactant>
<interactant intactId="EBI-2548993">
<id>P03495</id>
<label>NS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8160716">
<id>P29353-1</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1000553">
<id>P29353-2</id>
</interactant>
<interactant intactId="EBI-475981">
<id>P08069</id>
<label>IGF1R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1000553">
<id>P29353-2</id>
</interactant>
<interactant intactId="EBI-959949">
<id>P28482</id>
<label>MAPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9691288">
<id>P29353-7</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform p46Shc</molecule>
<subcellularLocation>
<location evidence="25">Mitochondrion matrix</location>
</subcellularLocation>
<text>Localized to the mitochondria matrix. Targeting of isoform p46Shc to mitochondria is mediated by its first 32 amino acids, which behave as a bona fide mitochondrial targeting sequence. Isoform p52Shc and isoform p66Shc, that contain the same sequence but more internally located, display a different subcellular localization.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform p66Shc</molecule>
<subcellularLocation>
<location evidence="15">Mitochondrion</location>
</subcellularLocation>
<text evidence="15">In case of oxidative conditions, phosphorylation at 'Ser-36' of isoform p66Shc, leads to mitochondrial accumulation.</text>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<event type="alternative splicing"/>
<isoform>
<id>P29353-1</id>
<name>p66Shc</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P29353-2</id>
<name>p52Shc</name>
<sequence type="described" ref="VSP_016108"/>
</isoform>
<isoform>
<id>P29353-3</id>
<name>p46Shc</name>
<sequence type="described" ref="VSP_016107"/>
</isoform>
<isoform>
<id>P29353-5</id>
<name>5</name>
<sequence type="described" ref="VSP_040090 VSP_040091"/>
</isoform>
<isoform>
<id>P29353-6</id>
<name>6</name>
<sequence type="described" ref="VSP_040092"/>
</isoform>
<isoform>
<id>P29353-7</id>
<name>7</name>
<sequence type="described" ref="VSP_016108 VSP_040092"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Widely expressed. Expressed in neural stem cells but absent in mature neurons.</text>
</comment>
<comment type="domain">
<text evidence="15">In response to a variety of growth factors, isoform p46Shc and isoform p52Shc bind to phosphorylated Trk receptors through their phosphotyrosine binding (PID) and/or SH2 domains. The PID and SH2 domains bind to specific phosphorylated tyrosine residues in the Asn-Pro-Xaa-Tyr(P) motif of the Trk receptors. Isoform p46Shc and isoform p52Shc are in turn phosphorylated on three tyrosine residues within the extended proline-rich domain. These phosphotyrosines act as docking site for GRB2 and thereby are involved in Ras activation (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="15 23 26 31 32 33 43 45 48 49 51 52">Phosphorylated by activated epidermal growth factor receptor. Phosphorylated in response to FLT4 and KIT signaling. Isoform p46Shc and isoform p52Shc are phosphorylated on tyrosine residues of the Pro-rich domain. Isoform p66Shc is phosphorylated on Ser-36 by PRKCB upon treatment with insulin, hydrogen peroxide or irradiation with ultraviolet light (By similarity). Tyrosine phosphorylated in response to FLT3 signaling (By similarity). Tyrosine phosphorylated by activated PTK2B/PYK2 (By similarity). Tyrosine phosphorylated by ligand-activated ALK. Tyrosine phosphorylated by ligand-activated PDGFRB. Tyrosine phosphorylated by TEK/TIE2. May be tyrosine phosphorylated by activated PTK2/FAK1; tyrosine phosphorylation was seen in an astrocytoma biopsy, where PTK2/FAK1 kinase activity is high, but not in normal brain tissue. Isoform p52Shc dephosphorylation by PTPN2 may regulate interaction with GRB2.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform p66Shc</molecule>
<text>Regulated by epigenetic modifications of its promoter region.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 5</molecule>
<text evidence="58">Produced by alternative splicing.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 6</molecule>
<text evidence="58">Produced by alternative splicing.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 7</molecule>
<text evidence="58">Produced by alternative splicing.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SHC1ID42287ch1q21.html"/>
</comment>
<dbReference type="EMBL" id="X68148">
<property type="protein sequence ID" value="CAA48251.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U73377">
<property type="protein sequence ID" value="AAB49972.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y09847">
<property type="protein sequence ID" value="CAA70977.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292143">
<property type="protein sequence ID" value="BAF84832.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315842">
<property type="protein sequence ID" value="BAF98733.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451255">
<property type="protein sequence ID" value="BAG70069.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451379">
<property type="protein sequence ID" value="BAG70193.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL451085">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53168.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53169.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53170.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53171.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014158">
<property type="protein sequence ID" value="AAH14158.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033925">
<property type="protein sequence ID" value="AAH33925.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1076.1">
<molecule id="P29353-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30881.1">
<molecule id="P29353-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44233.1">
<molecule id="P29353-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44234.1">
<molecule id="P29353-2"/>
</dbReference>
<dbReference type="PIR" id="S25776">
<property type="entry name" value="S25776"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001123512.1">
<molecule id="P29353-6"/>
<property type="nucleotide sequence ID" value="NM_001130040.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001123513.1">
<molecule id="P29353-2"/>
<property type="nucleotide sequence ID" value="NM_001130041.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001189788.1">
<molecule id="P29353-3"/>
<property type="nucleotide sequence ID" value="NM_001202859.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003020.2">
<molecule id="P29353-7"/>
<property type="nucleotide sequence ID" value="NM_003029.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_892113.4">
<molecule id="P29353-1"/>
<property type="nucleotide sequence ID" value="NM_183001.4"/>
</dbReference>
<dbReference type="PDB" id="1MIL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=482-583"/>
</dbReference>
<dbReference type="PDB" id="1N3H">
<property type="method" value="NMR"/>
<property type="chains" value="A=111-317"/>
</dbReference>
<dbReference type="PDB" id="1OY2">
<property type="method" value="NMR"/>
<property type="chains" value="A=111-317"/>
</dbReference>
<dbReference type="PDB" id="1QG1">
<property type="method" value="NMR"/>
<property type="chains" value="I=423-435"/>
</dbReference>
<dbReference type="PDB" id="1SHC">
<property type="method" value="NMR"/>
<property type="chains" value="A=127-317"/>
</dbReference>
<dbReference type="PDB" id="1TCE">
<property type="method" value="NMR"/>
<property type="chains" value="A=480-583"/>
</dbReference>
<dbReference type="PDB" id="1WCP">
<property type="method" value="Model"/>
<property type="chains" value="A=127-583"/>
</dbReference>
<dbReference type="PDB" id="2L1C">
<property type="method" value="NMR"/>
<property type="chains" value="A=127-317"/>
</dbReference>
<dbReference type="PDB" id="4JMH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="B=344-356"/>
</dbReference>
<dbReference type="PDB" id="4XWX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A=147-311"/>
</dbReference>
<dbReference type="PDB" id="5CZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B=345-353"/>
</dbReference>
<dbReference type="PDB" id="6DM4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="E/G/H=425-431"/>
</dbReference>
<dbReference type="PDBsum" id="1MIL"/>
<dbReference type="PDBsum" id="1N3H"/>
<dbReference type="PDBsum" id="1OY2"/>
<dbReference type="PDBsum" id="1QG1"/>
<dbReference type="PDBsum" id="1SHC"/>
<dbReference type="PDBsum" id="1TCE"/>
<dbReference type="PDBsum" id="1WCP"/>
<dbReference type="PDBsum" id="2L1C"/>
<dbReference type="PDBsum" id="4JMH"/>
<dbReference type="PDBsum" id="4XWX"/>
<dbReference type="PDBsum" id="5CZI"/>
<dbReference type="PDBsum" id="6DM4"/>
<dbReference type="BMRB" id="P29353"/>
<dbReference type="SMR" id="P29353"/>
<dbReference type="BioGRID" id="112361">
<property type="interactions" value="262"/>
</dbReference>
<dbReference type="CORUM" id="P29353"/>
<dbReference type="DIP" id="DIP-699N"/>
<dbReference type="ELM" id="P29353"/>
<dbReference type="IntAct" id="P29353">
<property type="interactions" value="158"/>
</dbReference>
<dbReference type="MINT" id="P29353"/>
<dbReference type="STRING" id="9606.ENSP00000401303"/>
<dbReference type="BindingDB" id="P29353"/>
<dbReference type="ChEMBL" id="CHEMBL5626"/>
<dbReference type="iPTMnet" id="P29353"/>
<dbReference type="PhosphoSitePlus" id="P29353"/>
<dbReference type="BioMuta" id="SHC1"/>
<dbReference type="DMDM" id="182676455"/>
<dbReference type="CPTAC" id="CPTAC-1366"/>
<dbReference type="CPTAC" id="CPTAC-1559"/>
<dbReference type="EPD" id="P29353"/>
<dbReference type="jPOST" id="P29353"/>
<dbReference type="MassIVE" id="P29353"/>
<dbReference type="MaxQB" id="P29353"/>
<dbReference type="PaxDb" id="P29353"/>
<dbReference type="PeptideAtlas" id="P29353"/>
<dbReference type="PRIDE" id="P29353"/>
<dbReference type="ProteomicsDB" id="54546">
<molecule id="P29353-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54547">
<molecule id="P29353-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54548">
<molecule id="P29353-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54549">
<molecule id="P29353-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54550">
<molecule id="P29353-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54551">
<molecule id="P29353-7"/>
</dbReference>
<dbReference type="ABCD" id="P29353">
<property type="antibodies" value="9 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="731">
<property type="antibodies" value="1148 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6464"/>
<dbReference type="Ensembl" id="ENST00000368445">
<molecule id="P29353-1"/>
<property type="protein sequence ID" value="ENSP00000357430"/>
<property type="gene ID" value="ENSG00000160691"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368450">
<molecule id="P29353-2"/>
<property type="protein sequence ID" value="ENSP00000357435"/>
<property type="gene ID" value="ENSG00000160691"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368453">
<molecule id="P29353-7"/>
<property type="protein sequence ID" value="ENSP00000357438"/>
<property type="gene ID" value="ENSG00000160691"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000448116">
<molecule id="P29353-6"/>
<property type="protein sequence ID" value="ENSP00000401303"/>
<property type="gene ID" value="ENSG00000160691"/>
</dbReference>
<dbReference type="GeneID" id="6464"/>
<dbReference type="KEGG" id="hsa:6464"/>
<dbReference type="UCSC" id="uc001ffv.4">
<molecule id="P29353-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6464"/>
<dbReference type="DisGeNET" id="6464"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160691.18"/>
<dbReference type="GeneCards" id="SHC1"/>
<dbReference type="HGNC" id="HGNC:10840">
<property type="gene designation" value="SHC1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160691">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="600560">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P29353"/>
<dbReference type="OpenTargets" id="ENSG00000160691"/>
<dbReference type="PharmGKB" id="PA35746"/>
<dbReference type="eggNOG" id="KOG3697">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000182870"/>
<dbReference type="HOGENOM" id="CLU_029532_2_0_1"/>
<dbReference type="InParanoid" id="P29353"/>
<dbReference type="KO" id="K06279"/>
<dbReference type="OMA" id="FFPKMAN"/>
<dbReference type="OrthoDB" id="1351843at2759"/>
<dbReference type="PhylomeDB" id="P29353"/>
<dbReference type="TreeFam" id="TF315807"/>
<dbReference type="PathwayCommons" id="P29353"/>
<dbReference type="Reactome" id="R-HSA-1236382">
<property type="pathway name" value="Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250347">
<property type="pathway name" value="SHC1 events in ERBB4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167044">
<property type="pathway name" value="Signalling to RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180336">
<property type="pathway name" value="SHC1 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210993">
<property type="pathway name" value="Tie2 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2424491">
<molecule id="P29353-2"/>
<property type="pathway name" value="DAP12 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2428933">
<property type="pathway name" value="SHC-related events triggered by IGF1R"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2730905">
<molecule id="P29353-2"/>
<property type="pathway name" value="Role of LAT2/NTAL/LAB on calcium mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871796">
<molecule id="P29353-2"/>
<property type="pathway name" value="FCERI mediated MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871809">
<molecule id="P29353-2"/>
<property type="pathway name" value="FCERI mediated Ca+2 mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-354192">
<property type="pathway name" value="Integrin signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381038">
<property type="pathway name" value="XBP1(S) activates chaperone genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-512988">
<property type="pathway name" value="Interleukin-3, Interleukin-5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5637810">
<property type="pathway name" value="Constitutive Signaling by EGFRvIII"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654688">
<property type="pathway name" value="SHC-mediated cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654699">
<property type="pathway name" value="SHC-mediated cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654704">
<property type="pathway name" value="SHC-mediated cascade:FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654719">
<property type="pathway name" value="SHC-mediated cascade:FGFR4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-74749">
<property type="pathway name" value="Signal attenuation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-74751">
<property type="pathway name" value="Insulin receptor signalling cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8851805">
<molecule id="P29353-2"/>
<property type="pathway name" value="MET activates RAS signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853659">
<property type="pathway name" value="RET signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8983432">
<property type="pathway name" value="Interleukin-15 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9009391">
<property type="pathway name" value="Extra-nuclear estrogen signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020558">
<property type="pathway name" value="Interleukin-2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9026519">
<property type="pathway name" value="Activated NTRK2 signals through RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027284">
<property type="pathway name" value="Erythropoietin activates RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9034864">
<property type="pathway name" value="Activated NTRK3 signals through RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912526">
<property type="pathway name" value="Interleukin receptor SHC signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9634285">
<property type="pathway name" value="Constitutive Signaling by Overexpressed ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664565">
<property type="pathway name" value="Signaling by ERBB2 KD Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9665348">
<property type="pathway name" value="Signaling by ERBB2 ECD mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9665686">
<property type="pathway name" value="Signaling by ERBB2 TMD/JMD mutants"/>
</dbReference>
<dbReference type="SignaLink" id="P29353"/>
<dbReference type="SIGNOR" id="P29353"/>
<dbReference type="BioGRID-ORCS" id="6464">
<property type="hits" value="35 hits in 869 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SHC1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P29353"/>
<dbReference type="GeneWiki" id="SHC1"/>
<dbReference type="GenomeRNAi" id="6464"/>
<dbReference type="Pharos" id="P29353">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P29353"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P29353">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160691">
<property type="expression patterns" value="Expressed in left coronary artery and 246 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P29353">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P29353">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070435">
<property type="term" value="C:Shc-EGFR complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046875">
<property type="term" value="F:ephrin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048408">
<property type="term" value="F:epidermal growth factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005154">
<property type="term" value="F:epidermal growth factor receptor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005158">
<property type="term" value="F:insulin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005159">
<property type="term" value="F:insulin-like growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005168">
<property type="term" value="F:neurotrophin TRKA receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005543">
<property type="term" value="F:phospholipid binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0030971">
<property type="term" value="F:receptor tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005068">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase adaptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031532">
<property type="term" value="P:actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0098609">
<property type="term" value="P:cell-cell adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071363">
<property type="term" value="P:cellular response to growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035723">
<property type="term" value="P:interleukin-15-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038110">
<property type="term" value="P:interleukin-2-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036498">
<property type="term" value="P:IRE1-mediated unfolded protein response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071864">
<property type="term" value="P:positive regulation of cell proliferation in bone marrow"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046579">
<property type="term" value="P:positive regulation of Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007176">
<property type="term" value="P:regulation of epidermal growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0040008">
<property type="term" value="P:regulation of growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0090322">
<property type="term" value="P:regulation of superoxide metabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd01209">
<property type="entry name" value="PTB_Shc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd09925">
<property type="entry name" value="SH2_SHC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP00154"/>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00511"/>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR006019">
<property type="entry name" value="PID_Shc-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR006020">
<property type="entry name" value="PTB/PI_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR029586">
<property type="entry name" value="Shc1/ShcA"/>
</dbReference>
<dbReference type="InterPro" id="IPR035676">
<property type="entry name" value="SHC_SH2"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10337:SF13">
<property type="entry name" value="PTHR10337:SF13"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00640">
<property type="entry name" value="PID"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00629">
<property type="entry name" value="SHCPIDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00462">
<property type="entry name" value="PTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01179">
<property type="entry name" value="PID"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0341">Growth regulation</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<feature type="chain" description="SHC-transforming protein 1" id="PRO_0000097731">
<location>
<begin position="1"/>
<end position="583"/>
</location>
</feature>
<feature type="domain" description="PID" evidence="18">
<location>
<begin position="156"/>
<end position="339"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="19">
<location>
<begin position="488"/>
<end position="579"/>
</location>
</feature>
<feature type="region of interest" description="CH1">
<location>
<begin position="340"/>
<end position="487"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="411"/>
<end position="474"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="12">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="36"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 11 13 14">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="16">
<location>
<position position="154"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="45 48 52">
<location>
<position position="349"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="45 48 52">
<location>
<position position="350"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9 10 13 48 52">
<location>
<position position="427"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_040090" evidence="58">
<location>
<begin position="1"/>
<end position="214"/>
</location>
</feature>
<feature type="splice variant" description="In isoform p46Shc." id="VSP_016107" evidence="56">
<location>
<begin position="1"/>
<end position="155"/>
</location>
</feature>
<feature type="splice variant" description="In isoform p52Shc and isoform 7." id="VSP_016108" evidence="54 55 56">
<location>
<begin position="1"/>
<end position="110"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_040091" evidence="58">
<original>PLSSILG</original>
<variation>MSLCHRW</variation>
<location>
<begin position="215"/>
<end position="221"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7 and isoform 6." id="VSP_040092" evidence="55 57">
<original>P</original>
<variation>PA</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8191981." id="VAR_042428">
<original>A</original>
<variation>V</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8191979." id="VAR_051353">
<original>M</original>
<variation>V</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="mutagenesis site" description="Alters interaction with GRB2; isoform p52Shc (in vitro)." evidence="51">
<original>Y</original>
<variation>F</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with GRB2; isoform p52Shc (in vitro)." evidence="51">
<original>Y</original>
<variation>F</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA70977." ref="3" evidence="58">
<original>D</original>
<variation>N</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA70977." ref="3" evidence="58">
<original>L</original>
<variation>M</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA70977." ref="3" evidence="58">
<original>S</original>
<variation>P</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB49972." ref="2" evidence="58">
<original>V</original>
<variation>D</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB49972." ref="2" evidence="58">
<original>D</original>
<variation>E</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG70069/BAG70193." ref="5" evidence="58">
<original>V</original>
<variation>A</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="113"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="142"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="152"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="160"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="176"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="181"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="206"/>
<end position="208"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="215"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="220"/>
<end position="224"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="226"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="230"/>
<end position="236"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="238"/>
<end position="245"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="246"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="251"/>
<end position="256"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="257"/>
<end position="259"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="262"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="268"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="273"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="284"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="293"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="296"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="311"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="483"/>
<end position="485"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="487"/>
<end position="489"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="495"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="507"/>
<end position="512"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="514"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="518"/>
<end position="526"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="529"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="540"/>
<end position="543"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="548"/>
<end position="551"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="552"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="566"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="571"/>
<end position="573"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="12">
<location sequence="P29353-2">
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="12">
<location sequence="P29353-7">
<position position="1"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MIL"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N3H"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OY2"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1SHC"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1TCE"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XWX"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CZI"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250"/>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P98083"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5M824"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00148"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10194451"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10867024"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11349134"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11980671"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12925710"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14573619"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14665640"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15102829"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15272003"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15316024"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15488758"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15526160"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15837797"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17274988"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19172738"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20010870"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23846654"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23946459"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7537849"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7541045"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7544002"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7559478"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8155326"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8195171"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8874179"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8939605"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8940081"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9038210"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9121430"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9148935"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9233773"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9488479"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9566877"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9660833"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1623525"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19054851"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000305"/>
<sequence length="583" mass="62822" checksum="7EFA5CB185A548D1" modified="2008-04-08" version="4">MDLLPPKPKYNPLRNESLSSLEEGASGSTPPEELPSPSASSLGPILPPLPGDDSPTTLCSFFPRMSNLRLANPAGGRPGSKGEPGRAADDGEGIVGAAMPDSGPLPLLQDMNKLSGGGGRRTRVEGGQLGGEEWTRHGSFVNKPTRGWLHPNDKVMGPGVSYLVRYMGCVEVLQSMRALDFNTRTQVTREAISLVCEAVPGAKGATRRRKPCSRPLSSILGRSNLKFAGMPITLTVSTSSLNLMAADCKQIIANHHMQSISFASGGDPDTAEYVAYVAKDPVNQRACHILECPEGLAQDVISTIGQAFELRFKQYLRNPPKLVTPHDRMAGFDGSAWDEEEEEPPDHQYYNDFPGKEPPLGGVVDMRLREGAAPGAARPTAPNAQTPSHLGATLPVGQPVGGDPEVRKQMPPPPPCPGRELFDDPSYVNVQNLDKARQAVGGAGPPNPAINGSAPRDLFDMKPFEDALRVPPPPQSVSMAEQLRGEPWFHGKLSRREAEALLQLNGDFLVRESTTTPGQYVLTGLQSGQPKHLLLVDPEGVVRTKDHRFESVSHLISYHMDNHLPIISAGSELCLQQPVERKL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

